NOTCH1 mutation predicts better clinical survival benefit of tislelizumab in second-line esophageal squamous cell carcinoma: a RATIONALE-302 study biomarker analysis
收藏Figshare2024-08-19 更新2026-04-08 收录
下载链接：
https://figshare.com/articles/dataset/NOTCH1_mutation_predicts_better_clinical_survival_benefit_of_tislelizumab_in_second-line_esophageal_squamous_cell_carcinoma_a_RATIONALE-302_study_biomarker_analysis/26778598/1
下载链接
链接失效反馈官方服务：
资源简介：
In a mouse model of esophageal cancer, we conducted single-cell sequencing analysis of tumor tissues from mice with endogenous NOTCH1 knockout and control groups, finding that NOTCH1 mutation promotes a more immunoactive tumor microenvironment.
提供机构：
Jiao, Xi
创建时间：
2024-08-19
